Further, MPNST was included in the 2018 soft tissue sarcoma characterization study of TCGA, in which two of the included samples were identified as SUZ12 mutants in the publicly available data, although no comment was made on these findings in the publication [22]. This evidence concerns the gene SUZ12 and malignant peripheral nerve sheath tumor.